90 results
424B3
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Nov 23
Prospectus supplement
9:15am
investigation plan (“PIP”) demonstrating that Trappsol® Cyclo™ addresses the pediatric population. On January 12, 2017, Cyclo received Fast Track Designation … or detain products; or
require a product recall.
Any government investigation of alleged violations of law could require AMTI to expend significant
S-4/A
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
, which period will be extended to 12 years upon acceptance by the EMA’s Pediatric Committee of Cyclo’s pediatric investigation plan (“PIP … ; or
require a product recall.
Any government investigation of alleged violations of law could require AMTI to expend significant time and resources
S-4
m3ebyw
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
8-K
EX-10.1
k133bm7rv1eul qjevr9
20 Oct 23
Unregistered Sales of Equity Securities
2:19pm
425
EX-2.1
lnabd9vc7vd0xmg6 yr
21 Sep 23
Business combination disclosure
4:28pm
425
EX-10.1
24xg8k6
21 Sep 23
Business combination disclosure
4:28pm
8-K
EX-10.1
e9lygyhs 5ja9q50
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
8-K
EX-2.1
ag8zebk xxj
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
8-K
EX-10.1
lju3 jvxuut6esn7q1
5 Jun 23
Entry into a Material Definitive Agreement
9:22am
8-K
EX-10.1
6535mvgivxkn
4 May 23
Unregistered Sales of Equity Securities
3:42pm
8-K
EX-10.2
qvoup2
4 May 23
Unregistered Sales of Equity Securities
3:42pm
8-K
EX-10.1
zv9bv4yo236efely
24 Apr 23
Unregistered Sales of Equity Securities
9:24am